Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Global Compliance Strategic Planning for Compliance With the EU Medical Device Regulation By Nach Davé June 12, 2019 Consulting FAQ: How the EU Medical Devices Regulation Affects Existing Products By Nach Davé May 8, 2019 Medical and Regulatory Affairs The FDA’s New Guidance on Natural History Studies in Rare Diseases: What You Need to Know By Angi Robinson May 1, 2019 Clinical ResearchPhase 1 - Phase 4 Leadership Development and Becoming a More Effective Change-maker By Abie Ekangaki April 26, 2019 Clinical ResearchPhase 1 - Phase 4 Untapped Potential: Asia-Pacific’s Growing Role in Biotech Drug Research By Ashish Jain March 20, 2019 Global Compliance Data Protection Part 3: Key Considerations for Clinical Trial Recruitment By Victoria Watts March 13, 2019 Previous 1 …24 25 26 27 28 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today